![Manesh Naidu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Manesh Naidu
Geen lopende functies
Profiel
Manesh Naidu served as the General Manager-INOpulse Program at Ikaria, Inc. and as the Chief Business Officer & Vice President at Bellerophon Therapeutics, Inc. He received his undergraduate and graduate degrees from Birla Institute of Technology & Science and a graduate degree in business administration from Kellogg School of Management.
Eerdere bekende functies van Manesh Naidu
Bedrijven | Functie | Einde |
---|---|---|
IKARIA, INC. | Corporate Officer/Principal | - |
BELLEROPHON THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Opleiding van Manesh Naidu
Oklahoma State University | Graduate Degree |
Birla Institute of Technology & Science | Graduate Degree |
Kellogg School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BELLEROPHON THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Ikaria, Inc.
![]() Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |